Tobramycin

Analytical Profiles of Drug Substances and Excipients

Volumn 24, Issue C, 1996, Pages 579-613

  Dash, Alekha K ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000861670     PISSN: 10756280     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0099-5428(08)60703-0     Document Type: Article

References (71)

1. C. e Higgens and R. E. Kastner, Antimicrob. Agents Chemother., 1967, 324-331 (1971).
2. R. Q. Thompson and E. A. Presti, Antimicrob. Agents Chemother., 1967, 332-340 (1971).
3. H. C. Neu, J. Infect. Disease., 134 (Suppl.), S3-S19 (1976).
4. th Edition, Merck and Co., Inc., Rahway, N. J., USA, 1989, p. 1499.
5. K. F. Koch and J. A. Rhoades, Antimicrob. Agents. Chemother., 1970, 309-313 (1971).
6. Y. Takegi, T. Miyake, T. Tsuchiya, S. Umezaya and H. Umezaya, J. Antibiotics., 26, 403-406 (1973).
7. A. K. Dash, unpublished data.
8. K. F Koch, J. A. Rhoades, E. W. Hagaman and E. Wenkert, J. Am. Chem. Soc., 96, 3300-3305 (1974).
9. nd Edition., The Pharmaceutical Press, London, 1988, p. 1027.
10. nd Edition, Vol 3, Elsevier, NY, 1987, pp. 2256-2257.
11. A. K. Dash and R. Suryanarayanan, Pharm. Res., 8, 1159-1165 (1991).
12. th Edition, The Pharmaceutical Press, London, England, 1989, pp. 326-328.
13. nd Revision, United States Pharmacopeial Convention, Rockville, MD. 1989, p. 1381.
14. A. K. Dash., Ph. D. Thesis, University of Minnesota, 1990, p. 183.
15. rd Edition, Chapman and Hall, NY. 1984, p 174.
16. G. G. Raymond and J. L. Born, Drug Intel. Clin. Pharm., 20, 683-686 (1986).
17. V. Das Gupta, J. Clin. Pharm. Therapy, 13, 195-198 (1988).
18. J. A. Ryan, J. Pharm. Sci., 73, 1301-1302 (1984).
19. A. Csiba, J. Pharm. Pharmacol., 31, 115-116 (1979).
20. S. Sampath and D. H. Robinson, J. Pharm. Sci., 79, 428-431 (1990).
21. D. M. Barends, C. L. Zwaan and A. Hulschoof, J. Chromatogr., 225, 417-426 (1981).
22. P. M. Kabra, P. K. Bhatnagar, M. A. Nelson, J. H. Wall and L. J. Marton, Clin. Chem., 29, 672-674 (1983).
23. N. A. Athanikar, R. W. Jurgens Jr., R. J. Sturgeon L. A. Zober, P. P. Deluca and D. D. Papadimitriou, J. Parenteral Sci. Tech., 37, 125-128 (1983).
24. S. K. Maitra, T. T. Yoshikawa, J. L. Hansen, M. C. Schotz, and L. B. Guze, Am. J. Clin. Pathol., 71, 428-432 (1979).
25. S.-E, Back, I. Nilsson-Ehle and P. Nilsson-Ehle, Clin. Chem., 25, 1222-1225 (1979).
26. A. K. Dash and R. Suryanarayanan, J. Pharm. Biomed. Anal., 9, 237-245 (1991).
27. J. P. Anhalt and S. D. Brown, Clin. Chem., 24, 1940-1947 (1978).
28. E. E. Stobberingh, A. W. Houben and C. P. A. van Boven, J. Clin. Microb., 15, 795-801 (1982).
29. J. W. Mayhew and S. L. Gorbach, J. Chromatogr., 151, 133-146 (1978).
30. S. E. Edberg and A. Chu, Am. J. Med. Technol., 41, 99-105 (1975).
31. D. C. Shanson, C. J. Hince, and J. V. Daniels, J. Infect. Disease, 134 (Suppl), S104-S109 (1976).
32. K. Jones, J. Reynolds, T. O. Oei and J. W. Smith, Clin. Chem., 25, 1096-1098 (1979).
33. A. Broughton, J. E. Strong, L. K. Pickering and G. P. Bodey, Antimicrob. Agents Chemother., 10, 652-656 (1976).
34. E. L. Frank, S. Srinivasan, P. Labthavikul and H. C. Neu, J. Clin. Microb., 13, 93-96 (1981).
35. R. P, McKnight and J. E. Willis, Clin. Chem., 27, 1256-1261 (1981).
36. A. S. Lewis, G. Taylor, H. N. Rowe, H. O. Williams and M. H. Lewis, Am. J. Hosp. Pharm., 44, 568-571 (1987).
37. TDX Fluorescence Polarization Immunoassay System; Abbott Laboratories, Diagnostics Divison, North Chicago, IL 60064.
38. I. A. Cohen, J. M. DeKeyser and D. M. Hyder, Am. J. Hosp. Pharm., 42, 605-609 (1985).
39. Y. G. Tsay and R. J. Palmer, Clin Chem. Acta, 109, 151-157 (1981).
40. H. T. Karnes, J. C. Gudat, C. M. O'Donnell and J. D. Wineforder, Clin. Chem., 27, 249-252 (1981).
41. M. Sheehan and G. Caron, Ther. Drug. Monit., 7, 108-114 (1985).
42. D. A. Marble, J. A. Bosso and R. J. Townsend, Drug Int. Clin. Pharm., 20, 960-963 (1986).
43. K. S. Nance and G. R. Matzke, Am. J. Nephrol., 4, 240-243 (1984).
44. G. E. Hoff, P. O. Schiotz and J. Paulsen, Scand. J. Infect. Dis., 6, 333-337 (1974).
45. AHFS Drug Information 93, G. K. McEvoy ed., American Society of Hospital Pharmacists, MD, 1993, pp. 1695-1696.
46. N. Horikoshi, M. Valdivieso and G. P. Bodey, Am. J. Med. Sci., 266, 453-458 (1973).
47. W. R. Lockwood and J. D. Bower, Antimicrob. Agents Chemother., 3, 215-219 (1973).
48. J. Klastersky, D. Daneau and V. DeMaereaer, Clin. Pharmacol. Ther., 14, 104-111 (1973).
49. B. R. Meyers and S. Z. Hirschman, J. Clin. Pharmacol. New Drugs, 12, 321-324 (1972).
50. C. Regamey, R. C. Gordon and W. M. W. Kirby, Clin. Pharmacol. Ther., 4, 396-403 (1973).
51. V. K. Simon, E. U. Mosinger and V. Malerczy, Antimicrob. Agents Chemotherapy, 3, 444-450 (1973).
52. H. Lode, P. Kemmerich and P. Koeppe, Antimicrob. Agents Chemotherapy, 8, 396-401 (1975).
53. B. C. Stanford and S. Dixson, Lancet, 1, 378-379 (1974).
54. Z. Takase, H. Shirauji, M. Uchida and T Sugawa, Chemotherapy, 23, 1378 (1975).
55. M. Uwaydah, S. Bibi and S. Salman, J. Antimicrob. Chemother., 1, 429-437 (1975).
56. R. Motomura, N. Nakajima and S. Miura., Chemotherapy, 23, 1403-1408 (1975).
57. A. B. Kaiser and Z. A. McGee, Clin. Res., 22, 33A (1974).
58. H. B. Hawley, R. Lewis, D. R. Swartz and D. W. Gump, Curr. Ther. Res., 16, 414-423 (1974).
59. K. Konomi, Y. Yamamoto, K. Egashira, Y. Kawauchi, T. Furusawa and T. Hisatsugu, Chemotherapy, 23, 239 (1975).
60. T. Iwasawa, Chemotherapy, 23, 1168 (1975).
61. C. H. Ramirez-Ronda, K. Holmes and J. P. Sandford, J. Clin. Invest., 53, 63A (1974).
62. R. C. Gordon, C. Regamey and W. M. Kirby, Antimicrob. Agents Chemotherapy, 2, 214-216 (1972).
63. K. G. Naber, S. R. Westenfelder and P. O. Madsen, Antimicrob. Agents Chemotherapy, 3, 469-473 (1973).
64. U. Ulmann, J. Antimicrob. Chemotherapy, 2, 213-214 (1976).
65. H. Ymada, T. Ichihashi and H. Kinoshita, Chemotherapy, 23, 900-907 (1975).
66. J.-C. Pechere and R. Dugal, J. Infect. Dis., 134 (Suppl.), S118-S124 (1976).
67. J. R. Black and R. S. Griffith, "Comparative pharmacology of tobramycin and gentamycin in adult volunteers", in Tobramycin: selected proceedings from the Eighth International Congress of Chemotherapy, Athens, 1973, Excerpta Media, Amsterdam, 1974, pp. 24-30.
68. G. Jaffe, B. R. Meyers and S. Z. Hirshman, Antimicrob. Agents Chemotherapy, 5, 611-616, 1974.
69. Material Safety Data Sheet for tobramycin, USP reference standard, United States Pharmacopeial Convention, Rockville, MD. 1988, p. 3.
70. F. DeRosa, U. Buoncristiani, P. Capitanucci and R. F. Frongillo, J. Int. Med. Res., 2, 100-114 (1974).
71. J. S. Welles, J. L. Emmeson, W. R. Gibson, R. Nickander, N. V. Owen and R. C. Anderson, Toxicol. Appl. Pharmacol., 25, 398-409 (1973).